Landscapes / Targets
CDK2
12 drugs act on CDK2, in 23 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs12
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Dec 2026Phase 3 trial completes | |||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer, HR-positive, HER2-negative Breast Neoplasms and 3 more | ||||
| Open drug page | |||||
— |
Phase 3 | 27 Apr 2027Phase 2 trial completes | |||
| Next date | 27 Apr 2027 · Phase 2 trial completes | ||||
| Also tested for | Ovarian Cancer, Renal Impairment and 2 more | ||||
| Open drug page | |||||
— |
Pfizer · Public PFE |
Phase 2 | 31 Dec 2026Phase 2 trial completes | ||
| Next date | 31 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Breast Cancer, Small Cell Lung Cancer and 2 more | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 1/2 | 30 Jun 2027Phase 1/2 trial completes | ||
| Next date | 30 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC) | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jul 2027Phase 1/2 trial completes | |||
| Next date | Jul 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Breast Cancer, Breast Cancer Metastatic and 7 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Jan 2028Phase 1/2 trial completes | |||
| Next date | 31 Jan 2028 · Phase 1/2 trial completes | ||||
| Also tested for | HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer and 7 more | ||||
| Open drug page | |||||
— |
Roche · Public ROG.SW |
Phase 1/2 | 31 Aug 2028Phase 1/2 trial completes | ||
| Next date | 31 Aug 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Breast Cancer, Advanced or Metastatic Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Dec 2026Phase 1 trial completes | |||
| Next date | 30 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Breast Cancer, Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Jul 2027Phase 1 trial completes | |||
| Next date | 31 Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC) and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2028Phase 1 trial completes | |||
| Next date | Jan 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor Cancer, Metastatic Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2029Phase 1 trial completes | |||
| Next date | Jan 2029 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor, Advanced Solid Tumor and 26 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Breast Cancer, Small Cell Lung Cancer and 10 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 12 of 12 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026